Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      No clinical trials need for Ayurveda, Unani, Siddha Medicines: Government of India

      No clinical trials need for Ayurveda, Unani, Siddha Medicines: Government of India

      Ruby Khatun Khatun11 July 2018 4:26 PM IST
      New Delhi: Through a recent notification, the Government of India has clarified that no clinical trials are required for issuing licenses patented or...
      Lupin gets USFDA approval for generic malaria drug

      Lupin gets USFDA approval for generic malaria drug

      Ruby Khatun Khatun11 July 2018 10:30 AM IST
      New Delhi: Drug firm Lupin said it has received approval from the US health regulator for Hydroxychloroquine Sulfate tablets, which is used to treat...
      Dr Reddys ties up with UCB to market epilepsy drug in India

      Dr Reddy's ties up with UCB to market epilepsy drug in India

      Ruby Khatun Khatun11 July 2018 10:15 AM IST
      New Delhi: Dr Reddy's Laboratories and UCB, a biopharmaceutical company announced they have entered into a distribution and co-promotion agreement for...
      Odisha, Tata Trust plan Rs 1,000 crore cancer care facilities

      Odisha, Tata Trust plan Rs 1,000 crore cancer care facilities

      Ruby Khatun Khatun11 July 2018 10:15 AM IST
      New Delhi: Odisha government and Tata Trust will jointly spend Rs 1,000 crore for development of cancer care facilities in the state in next five...
      Pfizer delays drug price hikes after talking with Trump

      Pfizer delays drug price hikes after talking with Trump

      Ruby Khatun Khatun11 July 2018 9:45 AM IST
      WASHINGTON/NEW YORK: Pfizer Inc said it was deferring drug price increases for no more than six months after the company’s chief executive officer had...
      Sanofi halts production at Pyrenees plant after pollution complaint

      Sanofi halts production at Pyrenees plant after pollution complaint

      Ruby Khatun Khatun11 July 2018 9:30 AM IST
      PARIS: Drugmaker Sanofi has stopped production at a plant in the French Pyrenees after an environment body filed a complaint against what it said was...
      Fortis deal: IHH likely to appear as winner with Rs 4,700-5,400 crore bid

      Fortis deal: IHH likely to appear as winner with Rs 4,700-5,400 crore bid

      Ruby Khatun Khatun10 July 2018 3:27 PM IST
      Mumbai: Malaysia's IHH Healthcare Berhad is likely to appear as the highest bidder of the latest Fortis Healthcare Bid with the controlling stake of...
      Akshay Kumar appointed brand ambassador for Sun Pharmas Revital H

      Akshay Kumar appointed brand ambassador for Sun Pharma's Revital H

      Ruby Khatun Khatun10 July 2018 10:30 AM IST
      Mumbai: Sun Pharma Consumer Healthcare, a division of Sun Pharmaceutical Industries Ltd, announced that it has signed Bollywood star Akshay Kumar as...
      China agrees to cut tariffs on Indian cancer drugs: Foreign Ministry

      China agrees to cut tariffs on Indian cancer drugs: Foreign Ministry

      Ruby Khatun Khatun10 July 2018 10:15 AM IST
      Beijing: India and China have reached an agreement on the reduction of tariffs on the import of Indian medicines, particularly cancer drugs, to China,...
      Credit Suisse sees improvement in margins for Sun Pharma, Cipla

      Credit Suisse sees improvement in margins for Sun Pharma, Cipla

      Ruby Khatun Khatun10 July 2018 10:00 AM IST
      New Delhi: The June quarter earnings should be weak for Cadila Healthcare and Lupin with sharp declines in the US sales on a QoQ basis, said global...
      Trump slams Pfizer after July 1 drug price hikes

      Trump slams Pfizer after July 1 drug price hikes

      Ruby Khatun Khatun10 July 2018 9:45 AM IST
      NEW YORK/WASHINGTON: U.S. President Donald Trump on Monday took aim at Pfizer Inc and other U.S. drugmakers after they raised prices on some of their...
      FSSAI develops tool kit to promote safe, healthy food

      FSSAI develops tool kit to promote safe, healthy food

      Ruby Khatun Khatun10 July 2018 9:30 AM IST
      New Delhi: Seeking to promote safe and healthy food, FSSAI said it will provide a training tool kit to health workers at the proposed 1.5 lakh...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok